513 related articles for article (PubMed ID: 27094260)
1. Insights on adaptive and innate immunity in canine leishmaniosis.
Hosein S; Blake DP; Solano-Gallego L
Parasitology; 2017 Jan; 144(1):95-115. PubMed ID: 27094260
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous immune mechanisms in canine leishmaniosis due to Leishmania infantum.
Papadogiannakis EI; Koutinas AF
Vet Immunol Immunopathol; 2015 Feb; 163(3-4):94-102. PubMed ID: 25555497
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
4. Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection.
Hosein S; Rodríguez-Cortés A; Blake DP; Allenspach K; Alberola J; Solano-Gallego L
PLoS One; 2015; 10(10):e0140325. PubMed ID: 26465878
[TBL] [Abstract][Full Text] [Related]
5. Feline leishmaniosis: Is the cat a small dog?
Pennisi MG; Persichetti MF
Vet Parasitol; 2018 Feb; 251():131-137. PubMed ID: 29426470
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum anti-Leishmania antibody levels and acute phase proteins in dogs with canine leishmaniosis.
Cantos-Barreda A; Escribano D; Cerón JJ; Bernal LJ; Furlanello T; Tecles F; Pardo-Marín L; Martínez-Subiela S
Vet Parasitol; 2018 Aug; 260():63-68. PubMed ID: 30197018
[TBL] [Abstract][Full Text] [Related]
7. An investigation of polymorphisms in innate and adaptive immune response genes in canine leishmaniosis.
Soutter F; Solano-Gallego L; Attipa C; Gradoni L; Fiorentino E; Foglia Manzillo V; Oliva G; Tasker S; Helps C; Catchpole B
Vet Parasitol; 2019 May; 269():34-41. PubMed ID: 31079826
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors 2, 4 and 7, interferon-gamma and interleukin 10, and programmed death ligand 1 transcripts in skin from dogs of different clinical stages of leishmaniosis.
Ordeix L; Montserrat-Sangrà S; Martínez-Orellana P; Baxarias M; Solano-Gallego L
Parasit Vectors; 2019 Dec; 12(1):575. PubMed ID: 31806038
[TBL] [Abstract][Full Text] [Related]
9. Total serum IgD from healthy and sick dogs with leishmaniosis.
Martínez-Orellana P; Maristany C; Baxarias M; Álvarez-Fernández A; Baldassarre A; Ordeix L; Solano-Gallego L
Parasit Vectors; 2019 Mar; 12(1):119. PubMed ID: 30909975
[TBL] [Abstract][Full Text] [Related]
10. Canine Leishmania vaccines: still a long way to go.
Gradoni L
Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
[TBL] [Abstract][Full Text] [Related]
11. Immunologic progression of canine leishmaniosis following vertical transmission in United States dogs.
Vida B; Toepp A; Schaut RG; Esch KJ; Juelsgaard R; Shimak RM; Petersen CA
Vet Immunol Immunopathol; 2016 Jan; 169():34-8. PubMed ID: 26827836
[TBL] [Abstract][Full Text] [Related]
12. TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment.
Montserrat-Sangrà S; Alborch L; Ordeix L; Solano-Gallego L
Vet Parasitol; 2016 Sep; 228():172-179. PubMed ID: 27692322
[TBL] [Abstract][Full Text] [Related]
13. Detecting antibodies to Leishmania infantum in horses from areas with different epizooticity levels of canine leishmaniosis and a retrospective revision of Italian data.
Gazzonis AL; Bertero F; Moretta I; Morganti G; Mortarino M; Villa L; Zanzani SA; Morandi B; Rinnovati R; Vitale F; Manfredi MT; Cardoso L; Veronesi F
Parasit Vectors; 2020 Oct; 13(1):530. PubMed ID: 33092640
[TBL] [Abstract][Full Text] [Related]
14. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
[TBL] [Abstract][Full Text] [Related]
15. Canine neutrophils activate effector mechanisms in response to Leishmania infantum.
Pereira M; Valério-Bolas A; Santos-Mateus D; Alexandre-Pires G; Santos M; Rodrigues A; Rocha H; Santos A; Martins C; Tomas A; Passero F; da Fonseca IP; Santos-Gomes G
Vet Parasitol; 2017 Dec; 248():10-20. PubMed ID: 29173534
[TBL] [Abstract][Full Text] [Related]
16. Remaining vigilant for the exotic: cases of imported canine leishmaniosis in Australia 2000-2011.
Cleare E; Mason K; Mills J; Gabor M; Irwin PJ
Aust Vet J; 2014 Apr; 92(4):119-27. PubMed ID: 24673139
[TBL] [Abstract][Full Text] [Related]
17. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
Gravino AE
Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
[TBL] [Abstract][Full Text] [Related]
18. Canine leishmaniasis. Immunophenotypic profile of leukocytes in different compartments of symptomatic, asymptomatic and treated dogs.
Alexandre-Pires G; de Brito MT; Algueró C; Martins C; Rodrigues OR; da Fonseca IP; Santos-Gomes G
Vet Immunol Immunopathol; 2010 Oct; 137(3-4):275-83. PubMed ID: 20615553
[TBL] [Abstract][Full Text] [Related]
19. Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine.
Dantas-Torres F
Vet Parasitol; 2006 Oct; 141(1-2):1-8. PubMed ID: 16750885
[TBL] [Abstract][Full Text] [Related]
20. Identification of two highly performing Leishmania infantum antigens for serodiagnosis of canine leishmaniosis.
Rami M; Atarhouch T; Dakkak A
Vet Parasitol; 2005 Nov; 134(1-2):25-31. PubMed ID: 16076527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
